Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer.
Scribner JA, Brown JG, Son T, Chiechi M, Li P, Sharma S, Li H, De Costa A, Li Y, Chen Y, Easton A, Yee-Toy NC, Chen FZ, Gorlatov S, Barat B, Huang L, Wolff CR, Hooley J, Hotaling TE, Gaynutdinov T, Ciccarone V, Tamura J, Koenig S, Moore PA, Bonvini E, Loo D. Scribner JA, et al. Among authors: de costa a. Mol Cancer Ther. 2020 Nov;19(11):2235-2244. doi: 10.1158/1535-7163.MCT-20-0116. Epub 2020 Sep 23. Mol Cancer Ther. 2020. PMID: 32967924
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.
Berezhnoy A, Sumrow BJ, Stahl K, Shah K, Liu D, Li J, Hao SS, De Costa A, Kaul S, Bendell J, Cote GM, Luke JJ, Sanborn RE, Sharma MR, Chen F, Li H, Diedrich G, Bonvini E, Moore PA. Berezhnoy A, et al. Among authors: de costa a. Cell Rep Med. 2020 Dec 22;1(9):100163. doi: 10.1016/j.xcrm.2020.100163. eCollection 2020 Dec 22. Cell Rep Med. 2020. PMID: 33377134 Free PMC article.
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
Luke JJ, Patel MR, Blumenschein GR, Hamilton E, Chmielowski B, Ulahannan SV, Connolly RM, Santa-Maria CA, Wang J, Bahadur SW, Weickhardt A, Asch AS, Mallesara G, Clingan P, Dlugosz-Danecka M, Tomaszewska-Kiecana M, Pylypenko H, Hamad N, Kindler HL, Sumrow BJ, Kaminker P, Chen FZ, Zhang X, Shah K, Smith DH, De Costa A, Li J, Li H, Sun J, Moore PA. Luke JJ, et al. Among authors: de costa a. Nat Med. 2023 Nov;29(11):2814-2824. doi: 10.1038/s41591-023-02593-0. Epub 2023 Oct 19. Nat Med. 2023. PMID: 37857711 Free PMC article. Clinical Trial.
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647.
Gendreau SB, Ventura R, Keast P, Laird AD, Yakes FM, Zhang W, Bentzien F, Cancilla B, Lutman J, Chu F, Jackman L, Shi Y, Yu P, Wang J, Aftab DT, Jaeger CT, Meyer SM, De Costa A, Engell K, Chen J, Martini JF, Joly AH. Gendreau SB, et al. Among authors: de costa a. Clin Cancer Res. 2007 Jun 15;13(12):3713-23. doi: 10.1158/1078-0432.CCR-06-2590. Clin Cancer Res. 2007. PMID: 17575237
The Exocrine Appendix. Darwin's vestige.
de Costa A. de Costa A. ANZ J Surg. 2025 Jan 1. doi: 10.1111/ans.19333. Online ahead of print. ANZ J Surg. 2025. PMID: 39743765 No abstract available.
Personalized azithromycin treatment rules for children with watery diarrhea using machine learning.
Kim SS, Codi A, Platts-Mills JA, Pavlinac P, Manji K, Sudfeld C, Duggan CP, Dube Q, Bar-Zeev N, Kotloff K, Sow SO, Sazawal S, Singa BO, Walson J, Qamar F, Ahmed T, De Costa A, Benkeser D, Rogawski McQuade ET. Kim SS, et al. Among authors: de costa a. medRxiv [Preprint]. 2024 Oct 28:2024.10.27.24316217. doi: 10.1101/2024.10.27.24316217. medRxiv. 2024. PMID: 39574840 Free PMC article. Preprint.
Characteristics and outcomes of children 2-23 months of age with prolonged diarrhoea: A secondary analysis of data from the 'Antibiotics for Children with Diarrhea' trial.
Parvin I, Shahid ASMSB, Nuzhat S, Ackhter MM, Alam T, Kabir MF, Khanam S, Sazawal S, Dhingra U, Walson JL, Singa BO, Kotloff KL, Sow SO, Bar-Zeev N, Dube Q, Qamar FN, Yousafzai MT, Manji K, Duggan CP, Bahl R, De Costa A, Simon J, Ashorn P, Ahmed T, Chisti MJ. Parvin I, et al. Among authors: de costa a. J Glob Health. 2024 Oct 11;14:04196. doi: 10.7189/jogh.14.04196. J Glob Health. 2024. PMID: 39388679 Free PMC article. Clinical Trial.
The 77th World Health Assembly resolution calling for newborn screening, diagnosis, and management of birth defects: moving towards action in low-income and middle-income countries.
Iroh Tam PY, Padilla CD, Zlotkin S, Ayede AI, Banu T, Kayita J, Khanna R, Rao SP, Siddeeg K, Walani S, de Costa A. Iroh Tam PY, et al. Among authors: de costa a. Lancet Glob Health. 2024 Nov;12(11):e1754-e1755. doi: 10.1016/S2214-109X(24)00335-8. Epub 2024 Sep 16. Lancet Glob Health. 2024. PMID: 39299254 Free article. No abstract available.
Integrated multisectoral interventions to mitigate the risk of low birth weight in low- and middle-income country settings: Implementation considerations for programs from a WHO expert consultation.
WHO Consultative Group on multisectoral programmatic interventions to reduce the risk of low birth weight. WHO Consultative Group on multisectoral programmatic interventions to reduce the risk of low birth weight. J Glob Health. 2024 Sep 13;14:03033. doi: 10.7189/jogh.14.03033. J Glob Health. 2024. PMID: 39268661 Free PMC article. No abstract available.
172 results